Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Pharmabiz
49m
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers ...
2h
Immutep (ASX:IMM) announces positive results in head and neck cancer treatment
Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company's latest results in head and neck cancer.
5h
This US stock is crushing Nvidia's performance this year: Is it too late to buy?
Few companies have attracted more attention this year than Nvidia. The chipmaker is on a roll thanks to the rapid rise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Alabama mass shooting
Daylight saving time
Visits US ammunition plant
Ga. suspect's mom indicted
Pandas leaving for China
Drug price challenge revived
Released after guilty plea
Donlon's homes searched
San Francisco homelessness
Boeing defense chief exits
SC 1st execution in 13 years
No. 1 at box office again
Former WA governor dies
ISR raids Al Jazeera office
Suns broadcaster dies
TN abortion law blocked
CA firefighter held for arson
Biden hosts 'Quad' summit
Robinson loses key staff
California plastic bag ban
Iran coal mine blast
Sesame Place suit verdict
CA bill to protect kids online
J&J unit files for bankruptcy
Hezbollah rockets hit Israel
Trump to campaign in MI
Dolphins legend Morris dies
Free COVID-19 tests
Economic speech this week
No govt. shutdown for now
PM Modi visits US
Related topics
Pembrolizumab
Lung cancer
United States
Summit Therapeutics
Food and Drug Administration
Feedback